INTRACOX Trademark

Trademark Overview

On Friday, January 30, 2015, a trademark application was filed for INTRACOX with the United States Patent and Trademark Office. The USPTO has given the INTRACOX trademark a serial number of 86519553. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 28, 2018. This trademark is owned by Pfizer Inc.. The INTRACOX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
intracox

General Information

Serial Number86519553
Word MarkINTRACOX
Filing DateFriday, January 30, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 28, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 1, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 9, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, May 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 28, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 3, 2017EXTENSION 4 GRANTED
Tuesday, October 3, 2017EXTENSION 4 FILED
Tuesday, October 3, 2017TEAS EXTENSION RECEIVED
Wednesday, April 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 24, 2017EXTENSION 3 GRANTED
Monday, April 24, 2017EXTENSION 3 FILED
Monday, April 24, 2017TEAS EXTENSION RECEIVED
Thursday, November 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2016EXTENSION 2 GRANTED
Thursday, October 13, 2016EXTENSION 2 FILED
Wednesday, November 2, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 13, 2016TEAS EXTENSION RECEIVED
Thursday, April 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2016EXTENSION 1 GRANTED
Tuesday, April 19, 2016EXTENSION 1 FILED
Tuesday, April 19, 2016TEAS EXTENSION RECEIVED
Tuesday, October 27, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 1, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 12, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 28, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 27, 2015ASSIGNED TO LIE
Wednesday, July 15, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 14, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, July 14, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 14, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, July 14, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, July 10, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 10, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 10, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 12, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 12, 2015NON-FINAL ACTION E-MAILED
Thursday, March 12, 2015NON-FINAL ACTION WRITTEN
Friday, March 6, 2015ASSIGNED TO EXAMINER
Monday, February 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 3, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

intracox preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases